The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Jensen Huang’s Nvidia exit raises fears over the future of AI financing
Nvidia CEO Jensen Huang’s reported departure rattled global markets, triggering concerns over the chipmaker’s leadership, AI investments and data-centre financing strategy. Nvidia shares tumbled, while